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Capsule Summary 30 
This prospective cohort study describes associations between the presence of filaggrin gene 31 
mutations and eczema, rhinitis and wheeze from as early as age six months, raising new 32 
questions regarding underlying mechanisms and timing of interventions.  33 
  34 
 35 
36 
Filaggrin gene defects are associated with eczema, wheeze and nasal disease during 37 
infancy: prospective study 38 
To the Editor: 39 
The protein filaggrin (FLG) is present in the skin and nasal epithelium and helps maintain the 40 
skin barrier while performing other functional roles1-3. Many studies have related the 41 
presence of common, loss-of-function filaggrin gene (FLG) defects to the incidence and 42 
severity of eczema3 and the severity of asthma4,5 during childhood.  43 
As allergy-related diseases, such as eczema or wheeze, often start from early infancy, it is 44 
important to explore whether the presence of FLG gene defects influences symptoms during 45 
infancy (6 and 12-month time points) and how these relate to progression of symptoms 46 
beyond infancy. If filaggrin does influence allergy-related symptom status during infancy, 47 
there may be justification for trialling interventions starting soon after birth, targeted towards 48 
infants with adverse FLG genotype, in order to explore beneficial effects on eczema, wheeze 49 
and other clinical outcomes as early as 6 and 12 months. It is known that FLG defects are 50 
associated with impaired skin barrier function, while skin barrier function defects are 51 
potentially correctable through the use of regular treatments6.  52 
A systematic review (December 2018) identified only two studies7,8, both retrospective, that 53 
have explored the link between filaggrin gene defects and allergy-related symptoms below 12 54 
months. Repeated measurements analyses in the Isle of Wight cohort showed that FLG 55 
defects were associated with an almost 3-fold increased risk of eczema during the first 12 56 
months of life. Nine out of nine infants with eczema at 3 months continued to have eczema at 57 
6 months of age6. This supported our retrospective analyses showing that presence of FLG 58 
mutations in two cohorts of modest size (Copenhagen n=379; Manchester n=503) was 59 
associated with a significant increase in eczema risk before the age of 12 months7. There was 60 
a significant enhancement of this risk with cat ownership at birth, thus adding further strength 61 
to the hypothesis that the genetically driven skin barrier defect may be playing a causal role 62 
through allergen entry7. We designed a prospective study to define the role of FLG gene 63 
defects on allergy-related outcomes during infancy.              64 
2312 pregnant women were recruited to the GO-CHILD study between 2009 and 2015 from 65 
8 National Health Service (NHS) Trusts in England and Scotland. The study was approved by 66 
the Tayside Committee on Medical Research and Ethics. Expectant mothers were invited 67 
during antenatal visits and a cord blood sample at birth or saliva in the postnatal period was 68 
collected for genotyping. (See Online Methods for details) The cord blood samples were 69 
stored at -80°C. Cord blood and saliva samples were transported to the University of Dundee 70 
for genotyping.  Infants with severe perinatal problems or congenital anomalies were 71 
excluded from the subsequent follow-up. The children were followed up for symptoms 72 
related to atopy at the ages of 6, 12 and 24 months by postal questionnaires sent to the carers 73 
(online Methods). Online Figure 1 shows the methodology and Online Table 1 describes the 74 
demographic characteristics of the cohort. Questions related to dry skin, eczema, wheeze, 75 
upper respiratory conditions and food allergies, and how these symptoms affected the child's 76 
life, including any visits to primary or secondary care and the prescribing of medication. For 77 
simplicity and greater accuracy through recall, responses for any of the three options - yes, 78 
no, don’t know - were used for analysis. 'Wheeze' was defined as 'breathing that makes a 79 
high-pitched whistling or squeaking sound from the chest, not the throat' and 'rhinitis' was 80 
defined as “a problem with sneezing, or a runny, or blocked nose when he/she did not have a 81 
cold or the flu”.  82 
All genetic analyses were anonymised. Genotyping for FLG R501X, 2282del4, S3247X and 83 
R2447X was performed as described in earlier papers 3-5. AA refers to the wild- type FLG 84 
genotype, Aa refers to heterozygous genotype with one of the mutations, and aa refers to 85 
homozygous genotype. The homozygous, heterozygous and compound heterozygous 86 
genotypes were considered together as Aa/aa. Data analyses were conducted using the IBM 87 
SPSS Statistics 146 software, Version 23 (IBM Corp., Armonk, and New York, USA), Stata 88 
version 15.2(College Station, TX: StataCorp LLC)  and Instat for Macintosh programmes. 89 
Binary logistic regression was used to estimate e odds ratios for dry or itchy skin for 90 
comparing the effects of the mutations.  For atopic outcomes i.e. eczema, wheeze and rhinitis, 91 
log-binomial regression was used to estimate relative risks..  Attendance at day-care and 92 
exposure to animals were included in all models as covariates after stepwise removal 93 
procedures (covariates with p<0.05 were retained).  Exposure to smoke, another potential 94 
covariate, did not contribute significantly to the model and was not associated with genotype 95 
in any subgroup tested and hence was excluded from the final analysis.  96 
The presence of dry or itchy skin, and a parent-reported diagnosis of eczema were found to 97 
be significantly increased in children with any FLG mutation at all the three time-points (6 98 
months, 1 year, 2 years following birth). At 6 months of age,  the heterozygous and 99 
homozygous genotypes for any of the FLG mutations were associated with higher risk of 100 
eczema (RR 1.82, 95%CI 1.39-2.39), dry or itchy skin (OR 2.71, 95%CI 1.61-4.55), wheeze 101 
(RR 1.63, 95%CI 1.00-2.65) and rhinitis (RR 1.46, 95%CI 1.06-2.01), compared to the wild 102 
type (Online Table 2). At age 1 year, the presence of one or more FLG mutations continued 103 
to be associated with higher risk of increased eczema (RR 1.80, 95%CI 1.39-2.32) and odds 104 
of dry or itchy skin (OR 2.28, 95%CI 1.32-3.92) compared to wild type, however, the 105 
association with wheeze and rhinitis were not significant (Online Table3). At age 2 years, the 106 
presence of one or more FLG mutations was associated with significantly higher risk of 107 
eczema (RR 1.40, 95%CI 1.00-1.97) and odds of dry or itchy skin (OR 1.83, 95%CI 1.02-108 
3.28), The associations with wheeze and rhinitis were not significant (Online Table 4). We 109 
report the results of the repeated measurements analysis in Table 5. 110 
 111 
Three-hundred thirty-one families returned completed questionnaires for their children at all 112 
three time-points, 6 months, 1 year and 2 years. This allowed us to explore whether there are 113 
differences in the time-course of allergy-related events in filaggrin-sufficient versus filaggrin-114 
deficient infants and children over the first two years of life. Infants and young children with 115 
FLG-deficient status were more likely to suffer from eczema; estimated difference in 116 
proportions (d) 0.12(95% CI, 0.01 to 0.24) and rhinitis; d=0.10 (95% CI, 0.02 to 0.19) over 6-117 
24 months in comparison to those with FLG-sufficient status; however, there were no 118 
observed differences for wheeze; d=0.04 (95% CI, -0.05 to 0.14). The bar charts show that, 119 
for those with a filaggrin mutation, prevalence (red portion of bar) of wheeze, eczema and 120 
rhinitis are all greater in the past 6, 12 and 24 months compared to those without a mutation.  121 
This pattern is less pronounced for wheeze and no difference was observed at 24 months. 122 
(online Figure 2) 123 
This is the first prospective study exploring the role of FLG gene defects on allergy-related 124 
disease outcomes at age 6 months. It indicates that the presence of one or more FLG gene 125 
defects from birth influences multiple aspects of allergy-related disease, including eczema, 126 
wheeze and nasal disease, at early infancy. The increased risk of filaggrin-associated nasal 127 
symptoms in 6-month olds may involve interactions between filaggrin deficiency states and 128 
allergen exposures to the nose occurring very early in life. The presence of FLG defects may 129 
also define a sub-phenotype of allergy-related disease that manifests over the first 2 years of 130 
life, with implications for allergy-related disease phenotype over later childhood. There are 131 
some limitations of this study. We did not plan and perform a formal a priori calculation of 132 
sample size and this is a weakness of our study. However, the rationale underlying our choice 133 
of sample size9 is presented in Online Methods. The sample size for all the analyses reported 134 
in this paper is at least twice the figure of 150 recommended by the paper9. We thus feel there 135 
is a high expectation that these results are valid and can be replicated in future meta-136 
analyses9. In addition, the recommendations9 refer to case-control studies, whereas this is a 137 
longitudinal cohort study, which has a more robust design. Findings of association studies 138 
must be supported by independent replication, with associations combining family- based and 139 
population- based analysis, with an odds ratio/relative risk and/or attributable risk that is 140 
high9. However, we have not found any published data to compare to and thus replicate our 141 
findings.  Being a prospective birth cohort study, there is a fair amount of work for new 142 
mothers in terms of completing the questionnaires and hence there was a relatively low return 143 
rate and complete data comprising all three questionnaires. We are also unable to comment 144 
on any possible effect of ethnicity variations as the majority of the participants were 145 
Caucasian. Future interventional studies directed at FLG-deficient populations from birth 146 
may show improvements in clinical outcomes beyond eczema from as early as 6 months of 147 
age.   148 
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The Influence of genetic and environmental factors on childhood 
diseases 
 
Postal questionnaire to assess asthma/allergy and infection 
 
Thank you for agreeing to participate in our study. Please fill out this questionnaire with 
the information about the first 6 months of your child’s life and return this in the pre-paid 
envelope that has been supplied. 
 
Name of Child: …………………………………………  Bar Code Sticker 
 
CHI / NHS Number: …………………………………… 
 
Date of Birth: …………………………………………… 
 
• Person completing questionnaire (tick box please): 
                                                  Mother□   Father□    Other□ 
 
• Date questionnaire completed: 
                                                 day ____ month ______ year ________                           










6 months Follow up questionnaire                                                                                 KB/Version3.0/01Jul12 
 
2 
Bar code sticker 
 
Questions on wheezing 
 
By “wheezing” we mean breathing that makes a high-pitched whistling or squeaking sound from 
the chest, not the throat 
 
1. Has your child had wheezing or whistling in the chest in the last 6 months?        Yes/ No                                                                                            
                                                                                                                        
If you answered “no” please skip to question 11. 
 
2. How old was your child when he/she first began to wheeze?        
                                                 __________ years _______ months  
3. In the first 6 months, has your child had wheezing or whistling in the chest during or soon after a 
cold or flu?                                                                                            Yes/ No 
                                                                                                            
4. In the first 6 months, has your child had wheezing or whistling in the chest even without having 
a cold or flu?                                                                                                  Yes/ No 
                                                                                                             
5. How many attacks of wheezing has your child had during the first 6 months? 
   □None         □ 1 to 3         □ 4 to 12          □ more than 12 
 
6. Do these attacks cause him/her to be short of breath? 
    □ yes, always             □ most of the time              □  occasionally             □  no, never 
 
7. Which of these two descriptions fits best your child’s wheeze?   (tick one only) 
a)  My child has only short attacks of wheeze, for example with colds. In between these attacks, 
he/she does not normally wheeze.                                                                    □ 
b) My child wheezes always or a lot of the time. With colds he/she has attacks with more severe 
wheeze.                                                                                                               □ 
8. In the first 6 months, how often, on average, has your child’s sleep been disturbed due to 
wheezing? 
      □ never woken with wheezing                      □ less than one night per week            
          □one or more nights per week   
 
9. In the first 6 months, how much did wheezing interfere with your child’s daily activities? 
  □ not at all                      □ a little                     □ a moderate amount                  □ a lot  
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10. In the first 6 months did the following things cause wheezing in your child? 
 
• exercise (playing)                                □ yes □ no □ don’t know  
• laughing, crying or excitement                                  □ yes □ no □  don’t know  
• contact with pets or other animals                                □yes □ no □  don’t know  
• food or drinks                                                                □yes □ no □ don’t know  
 
11. In the first 6 months, did your child suffer from rattly breathing (rattles)? 
       □ never                                                   □only with a cold                                                                               
       □sometimes even without a cold            □almost always  
 
12. Does your child attend day care or nursery?                                               Yes/ No 
 
13. Was your child breastfed?                                                                            Yes/ No  
If yes, how long:  □ less than a month                 □1-3 months                   □4-6 months  
                                                                                                             
14. During the first 6 months of life, did your child posit or vomit?  
      □  not at all                                   □  a little                               □   a lot  
 
15. Has your child had an itchy rash at any time in the first 6 months?                   Yes/ No  
      Has your child had this itchy skin condition in the last week?                            Yes/ No  
      How old was your child when this condition began………………………………………… 
 
 Has this skin condition ever affected the skin creases in the past – by skin creases we mean 
fronts of elbows, behind the knees, front of ankles, around the neck or around the eyes?                                                                             
Yes/ No 
 
16. In the first 6 months, has your child suffered from a dry skin in general? Yes/ No                                            
    Has your child suffered from any of the following skin complaints (Please tick one or more) 
  □Eczema       □ Cradle cap         □Nappy rash       □Facial spots        □ Heat rash  
17. If your child had a rash did you think at the time that this was related to your washing powder?                               
             Yes/ No  
What type of washing powder were you using at the time of the rash? 
□Biological                                  □Non-biological                                     □Not sure    
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Questions on ears, nose and throat 
 
18. In the first 6 months, how many times has your child had a cold or flu? 
           □Never                   □1 - 3 times                     □4 - 6 times                                      
           □7 -10 times       □more than 10 times  
 
19. How long does a cold usually last in your child? 
     □less than 1 week                              □1 to 2 weeks                                        
     □2 to 4 weeks                                     □more than 4 weeks  
 
20. In the first 6 months, has your child had a problem with sneezing, or a runny, or blocked nose 
when he/she did NOT have a cold or the flu?                                    Yes / No  
 
21. In the first 6 months, how much did this nose problem interfere with your child’s daily activities?  
□Not at all                     □a little                      □a moderate amount                     □a lot  
 
22. Over the first 6 months, has your child snored or had a blocked nose at night? 
                                                                                                                                 Yes/ No                           
  If yes, how often:    □only with a cold                 □sometimes even without a cold  
                                □almost always  
 
23. Did the snoring/blocked nose disturb your child’s sleep? 
    □not at all                 □a little                 □a moderate amount                   □ a lot  
 
Questions on coughing 
 
24. Does your child usually have a cough with colds?                                       Yes/ No 
 
25. Does your child have a cough even without having a cold? 
 
      □No, never                               □yes, sometimes                                    □yes, always  
 
26. Do you think that your child coughs more than other children?                    Yes/ No 
 
27. In the first 6 months, has your child had a dry cough at night, apart from a cough associated 
with a cold or a chest infection?                                                        Yes/ No                                                                                          
28. In the first 6months, did the following things cause coughing in your child? 




• exercise (playing)                                 □yes       □no       □don’t know  
• laughing, crying or excitement                              □yes        □no        □don’t know  
• contact with pets or other animals                                  □yes         □no        □don’t know  
• food or drinks                                                              □yes        □no      □don’t know  
 
Questions on your household 
 
29. Do you keep any household pets?                                                                Yes/No  
If yes, do you keep any of these pets? (tick as many as apply) 
   □Dog                           □Cat                            □Other furry pets                      □Bird  
 
30. Is the child exposed to smoking?       Yes/No  
 
31. Does the child’s mother smoke cigarettes?                                            Yes/No 
     If yes, how many per day?          □1 to 10                  □11 to 20           □more than 20  
32. Do any other household members smoke cigarettes?                            Yes/No 
 
If yes, how many per day (total of cigarettes)?  
        □1 to 10                                        □11 to 20                                    □more than 20  
 
33. How would you describe the location of your house? 
 
                                 □ In a street with very dense traffic (main road)  
 
                                □In a street with moderate traffic (residential road)  
 
                                 □ In a quiet street with little or no traffic 
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Questions about Infection  
Hospital Admissions 
Was your baby admitted to the Special Care Baby Unit? Yes/No 
• If YES why? 
             □Premature                      □Breathing problems   
            □Suspected infection                     □Confirmed infection  
• If infection what kind? □Chest  □Meningitis       □Blood           □Other?
 …………………………………………………… 
• Has your child had any/other admissions to hospital?  Yes/No  
If YES, How many times? …………………… 
Please fill this table for further information about your child hospital admission 
Name of hospital and 
Date of admission 
Age Diagnosis Treatment 
1st Admission 
Name of hospital 
……………………….. 
 
Date of Admission: 
……………………… 
 
 Meningitis    
Pneumonia    
Bronchiolitis    
Wheeze    
Blood infection (sepsis)   
Urinary tract infection  
Other………………………… 
Antibiotics through the vein 
   
Oral antibiotics  
Nebuliser   
Fluids through the vein                                              
    
Other………………….… 
2nd Admission 
Name of hospital 
…………………… 
 
Date of Admission: 
………………………. 
 Meningitis    
Pneumonia    
Bronchiolitis    
Wheeze    
Blood infection (sepsis)   
Urinary tract infection  
Other………………………… 
Antibiotics through the vein 
   
Oral antibiotics  
Nebuliser   
Fluids through the vein                                             
    
Other……………… 
3rd Admission 
Name of hospital 
…………………… 
 
Date of Admission: 
……………………….. 
 Meningitis    
Pneumonia    
Bronchiolitis    
Wheeze    
Blood infection (sepsis)   
Urinary tract infection  
Other………………………… 
Antibiotics through the vein 
   
Oral antibiotics  
Nebuliser   
Fluids through the vein                                             
    
Other……………… 
 
(Please find the attached tables if needed for more admission) 
 




1. Has your child ever visited the GP when unwell?                         Yes/No  
• If YES, How many times …………………………….. 
 (Please fill this table for further information about your child’s GP visit) 
Date/age of visit Symptoms Diagnosis Treatment 
 Cough   
Runny/blocked nose  




Viral cold     
Chest infection    
Bronchiolitis     
Wheeze    
Feeding problems   
Urinary tract infection        
Ear infection    
Other………………………… 
Advice only    
Oral antibiotics   
Inhalers    
Paracetamol/Calpol  
Ibuprofen/Nurofen   
Other………………… 
  Cough   
Runny/blocked nose  




Viral cold     
Chest infection    
Bronchiolitis     
Wheeze    
Feeding problems   
Urinary tract infection              
Ear infection    
Other………………………… 
Advice only    
Oral antibiotics   
Inhalers    
Paracetamol/Calpol  
Ibuprofen/Nurofen   
Other………………… 
 Cough   
Runny/blocked nose  




Viral cold     
Chest infection    
Bronchiolitis     
Wheeze    
Feeding problems   
Urinary tract infection         
Ear infection    
Other………………………… 
Advice only    
Oral antibiotics   
Inhalers    
Paracetamol/Calpol  
Ibuprofen/Nurofen   
Other………………… 
 Cough   
Runny/blocked nose  




Viral cold     
Chest infection    
Bronchiolitis     
Wheeze    
Feeding problems   
Urinary tract infection              
Ear infection    
Other………………………… 
Advice only    
Oral antibiotics   
Inhalers    
Paracetamol/Calpol  
Ibuprofen/Nurofen   
Other………………… 
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(Please find the attached tables if needed for more GP visit) 
Child’s Health at Home 
2. Are your child’s vaccinations up to date?    
    □Yes                       □No                   □Partly 
• Has your child been unwell at home but not needed to go to the GP’s? Yes/ No 
If Yes, Please tell us more about it. 




 Cough      
Runny/blocked nose   
Rash      
Temperature     
Diarrhoea/vomiting   
Other…………………. 
Observe only     
Inhalers     
Paracetamol (Calpol)    
And/or Ibuprofen (Nurofen)   
Other…………………… 
 Cough      
Runny/blocked nose   
Rash      
Temperature     
Diarrhoea/vomiting   
Other…………………. 
Observe only     
Inhalers     
Paracetamol (Calpol)    
And/or Ibuprofen (Nurofen)   
Other…………………… 
 Cough      
Runny/blocked nose   
Rash      
Temperature     
Diarrhoea/vomiting   
Other…………………. 
Observe only     
Inhalers     
Paracetamol (Calpol)    
And/or Ibuprofen (Nurofen)   
Other…………………… 
 Cough      
Runny/blocked nose   
Rash      
Temperature     
Diarrhoea/vomiting   
Other…………………. 
Observe only     
Inhalers     
Paracetamol (Calpol)    
And/or Ibuprofen (Nurofen)   
Other…………………… 
 
(Please find the attached tables if needed for more Child’s Health at Home)
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Did you have problems understanding this questionnaire?                   Yes □   no □ 
 
Please write any comments you have about your child’s health or about the questionnaire 







Thank you for completing the questionnaire. It will cost you nothing to return it if you use 
the pre-paid envelope provided (FREEPOST). No stamp required. 
 
 
For any queries please do not hesitate to contact us: 
Dr Kaninika Basu 
01273 696955, ext 2404 
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Questions about Infection  
Hospital Admissions 
Was your baby admitted to the Special Care Baby Unit? Yes/No 
• If YES why? 
             □Premature                      □Breathing problems   
            □Suspected infection                     □Confirmed infection  
• If infection what kind? □Chest  □Meningitis       □Blood           □Other?
 …………………………………………………… 
• Has your child had any/other admissions to hospital?  Yes/No  
If YES, How many times? …………………… 
Please fill this table for further information about your child hospital admission 
Name of hospital and 
Date of admission 
Age Diagnosis Treatment 
1st Admission 
Name of hospital 
……………………….. 
 
Date of Admission: 
……………………… 
 
 Meningitis    
Pneumonia    
Bronchiolitis    
Wheeze    
Blood infection (sepsis)   
Urinary tract infection  
Other………………………… 
Antibiotics through the vein 
   
Oral antibiotics  
Nebuliser   
Fluids through the vein                                              
    
Other………………….… 
2nd Admission 
Name of hospital 
…………………… 
 
Date of Admission: 
………………………. 
 Meningitis    
Pneumonia    
Bronchiolitis    
Wheeze    
Blood infection (sepsis)   
Urinary tract infection  
Other………………………… 
Antibiotics through the vein 
   
Oral antibiotics  
Nebuliser   
Fluids through the vein                                             
    
Other……………… 
3rd Admission 
Name of hospital 
…………………… 
 
Date of Admission: 
……………………….. 
 Meningitis    
Pneumonia    
Bronchiolitis    
Wheeze    
Blood infection (sepsis)   
Urinary tract infection  
Other………………………… 
Antibiotics through the vein 
   
Oral antibiotics  
Nebuliser   
Fluids through the vein                                     
    
Other……………… 
 
(Please find the attached tables if needed for more admission) 
 




3. Has your child ever visited the GP when unwell?                         Yes/No  
• If YES, How many times …………………………….. 
 (Please fill this table for further information about your child’s GP visit) 
Date/age of visit Symptoms Diagnosis Treatment 
 Cough   
Runny/blocked nose  




Viral cold     
Chest infection    
Bronchiolitis     
Wheeze    
Feeding problems   
Urinary tract infection        
Ear infection    
Other………………………… 
Advice only    
Oral antibiotics   
Inhalers    
Paracetamol/Calpol  
Ibuprofen/Nurofen   
Other………………… 
  Cough   
Runny/blocked nose  




Viral cold     
Chest infection    
Bronchiolitis     
Wheeze    
Feeding problems   
Urinary tract infection              
Ear infection    
Other………………………… 
Advice only    
Oral antibiotics   
Inhalers    
Paracetamol/Calpol  
Ibuprofen/Nurofen   
Other………………… 
 Cough   
Runny/blocked nose  




Viral cold     
Chest infection    
Bronchiolitis     
Wheeze    
Feeding problems   
Urinary tract infection         
Ear infection    
Other………………………… 
Advice only    
Oral antibiotics   
Inhalers    
Paracetamol/Calpol  
Ibuprofen/Nurofen   
Other………………… 
 Cough   
Runny/blocked nose  




Viral cold     
Chest infection    
Bronchiolitis     
Wheeze    
Feeding problems   
Urinary tract infection              
Ear infection    
Other………………………… 
Advice only    
Oral antibiotics   
Inhalers    
Paracetamol/Calpol  
Ibuprofen/Nurofen   
Other………………… 
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(Please find the attached tables if needed for more GP visit) 
Child’s Health at Home 
4. Are your child’s vaccinations up to date?    
    □Yes                       □No                   □Partly 
• Has your child been unwell at home but not needed to go to the GP’s? Yes/ No 
If Yes, Please tell us more about it. 




 Cough      
Runny/blocked nose   
Rash      
Temperature     
Diarrhoea/vomiting   
Other…………………. 
Observe only     
Inhalers     
Paracetamol (Calpol)    
And/or Ibuprofen (Nurofen)   
Other…………………… 
 Cough      
Runny/blocked nose   
Rash      
Temperature     
Diarrhoea/vomiting   
Other…………………. 
Observe only     
Inhalers     
Paracetamol (Calpol)    
And/or Ibuprofen (Nurofen)   
Other…………………… 
 Cough      
Runny/blocked nose   
Rash      
Temperature     
Diarrhoea/vomiting   
Other…………………. 
Observe only     
Inhalers     
Paracetamol (Calpol)    
And/or Ibuprofen (Nurofen)   
Other…………………… 
 Cough      
Runny/blocked nose   
Rash      
Temperature     
Diarrhoea/vomiting   
Other…………………. 
Observe only     
Inhalers     
Paracetamol (Calpol)    
And/or Ibuprofen (Nurofen)   
Other…………………… 
 
(Please find the attached tables if needed for more Child’s Health at Home) 
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The Influence of genetic and environmental factors on childhood diseases 
 
Postal questionnaire to assess asthma/allergy: Year 1 
 
Thank you for agreeing to participate in our study. Please fill out this questionnaire with the 
information about the first 1 year of your child’s life and return it in the pre-paid envelope that has 
been supplied. 
 
How to complete the questionnaire: Please tick the appropriate box 
Example: Person completing questionnaire (tick box please): 
                                                  Mother    Father      Other 
 
 
Name of Child: …………………………………………  Bar Code Sticker 
 
 
Date of Birth: …………………………………………… 
 
 Person completing questionnaire (tick box please): 
                                                                    Mother    Father    Other  
 
 Date questionnaire completed:          day ____ month ______ year ________                           
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1. In the last year, has your child had an ITCHY skin condition - by itchy we mean 
scratching or rubbing the skin)?                   
                      
IF YOU HAVE ANSWERED ‘NO’ PLEASE SKIP TO QUESTION 2 
IF YOU HAVE ANSWERED ‘YES’ PLEASE ANSWER THE QUESTIONS IN THE SHADED BOX 
BELOW: 
1b. Was this ITCHY skin condition coming and going for at least six months?  
 




1d. How old was your child when this skin condition began?                          months old 
 
1e. Has this skin condition ever affected the skin creases in the past –  
by skin creases we mean fronts of elbows, behind the knees, front of  
ankles, around the neck or around the eyes?                 
 
2. In the first year, has your child suffered from a dry skin in general? 
 
 
3.   In the first year, has your child suffered from any of the following skin 
complaints: (PLEASE TICK ALL THAT APPLY).       
 
 
4. In the first year, has your child ever had wheezing or whistling in the chest? 
By “wheezing” we mean breathing that makes a high-pitched whistling or squeaking 













Facial spots  
Nappy rash  
Yes  
No  
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IF YOU HAVE ANSWERED ‘NO’ PLEASE SKIP TO QUESTION 12 
IF YOU HAVE ANSWERED ‘YES’ PLEASE ANSWER THE QUESTIONS IN THE SHADED BOX 
BELOW: 
 
 4a.  How old was your child when he/she first began to wheeze?  
             
5.  In the first year, has your child had wheezing or whistling in the chest during 
or soon after a cold or flu? 
                                                                                                         










 8. Which of these two descriptions fits best your child’s wheeze?   (TICK ONE ONLY) 
 
9. In the first year, how often, on average, has your 







1 to 3  
4 to 12  
More than 12  
Yes, always  
Most of the time  
Occasionally  
No, never  
My child has only short attacks of wheeze, for example with colds. In between these attacks, 
he/she does not normally wheeze    
 
My child wheezes always or a lot of the time. With colds he/she has attacks with more severe 
wheeze   
 
never woken with wheezing    
less than one night per week    
one or more nights per week    
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10. In the first year, did any of the following things cause wheezing in your child? 
                                                                      Feeding; playing; exercise?  









                                                         Contact with pets or other animals? 
 
 








 12. Does your child usually have a cough with colds?                                        
   
 




14. Do you think that your child coughs more than other children?        
 
 
15. In the first year, has your child had a dry cough at night, apart from a cough 






Don’t know  
Yes  
No  
Don’t know  
Yes  
No  
Don’t know  
Yes  
No  





Yes, always  
Yes, sometimes  
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16. In the first year, did the following things cause coughing in your child? 
 
                                                              Feeding, playing or exercise?  
 
 
      laughing, crying or excitement?                                                                                                            
 
 
                                       
                                                      contact with pets or other animals? 
 
 




17. How often did your child see the GP for coughing or wheezing 
during the first 12months? 
 
 
             
18. In the first 12 months, has wheezing or asthma resulted in your child: 
 
                                                          being referred to a consultant in hospital  
                                       
                                                                                 being admitted to hospital         
                                                        
 
                                                   attending the casualty (A and E) department   
        
                                                  






Don’t know  
Yes  
No  
Don’t know  
Yes  
No  
Don’t know  
Yes  
No  
Don’t know  
Never  
Once  
2-3 times  
4-6 times  
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19. Did your child take any of the following drugs in the first 12 months? 
                                 Salbutamol, Ventolin, Bricanyl or other blue inhaler     
 
 
                             





                                    Steroid tablets (prednisolone) for asthma attacks   
 
 






21. In the first year, how many times has your child had 









23. In the first year, has your child had a problem with sneezing,  
or a runny, or blocked nose when he/she did NOT have a cold or the flu?  
 
24. In the first year, how much did this nose problem  




Don’t know  
Yes  
No  
Don’t know  
Yes  
No  
Don’t know  
Never  
Only with a cold  
Sometimes even without a cold  
Almost always  
Never  
1-3 times  
4-6 times  
7-10 times  
More than 10 times  
Less than 1 week  
1 to 2 weeks  
2 to 4 weeks  
More than 4 weeks  
Yes  
No  
Not at all  
A little  
A moderate amount  
A lot  
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25. Over the first 12months, has your child snored at night?                       
        
IF YOU HAVE ANSWERED ‘NO’ PLEASE SKIP TO QUESTION 26 
IF YOU HAVE ANSWERED ‘YES’ PLEASE ANSWER THE QUESTIONS IN THE SHADED BOX 
BELOW: 
 




25.b  Did the snoring disturb your child’s sleep? 
 
 
                         
 
 
26. In the first 12months, has your child had any ear infections? 
 
27. Has your child ever suffered from any of the following 
conditions? 
                                                                                                                                                       
                                                                                  pneumonia?         
 
       
                                               
                                                        whooping cough?  
 
                                                                              
 




                                      
                                                                                       croup? 
    
Yes  
No  
Only with a cold  
Sometimes even without a cold  
Almost always  
Not at all  
A little  
A moderate amount  
A lot  
No, never  
Yes, once  
Yes, more than once  
No, never  
Yes, once  
Yes, more than once  
No, never  
Yes, once  
Yes, more than once  
No, never  
Yes, once  
Yes, more than once  
No, never  
Yes, once  
Yes, more than once  
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28. Does your child attend day care, childminder, nursery school or 
play school?  
 
29. Was your child breastfed?                       
                                                       
 
If yes, how long:             
                                                                                                              
 
 
30. During the first year of life, did your child posit or vomit?  
 
                                                                                               
 
 
31. Do you think your child has a reaction to any food items? 
 
 
IF YOU HAVE ANSWERED ‘NO’ PLEASE SKIP TO QUESTION 32 
IF YOU HAVE ANSWERED ‘YES’ PLEASE ANSWER THE QUESTIONS IN THE SHADED BOX BELOW: 
31a. Does your child have a reaction to any of these foods? 
(PLEASE TICK ALL THAT APPLY) 
 
If you have ticked ‘other’, please describe the  
type of food that causes the reaction:……….. 
…………………………………………………… 
 
31b. What type of reaction does the food cause? (PLEASE 
TICK ALL THAT APPLY)  
 
If you have ticked ‘other’, please describe the  








less than a month   
1-3 months   
4-6 months  
more than 6 months  
Not at all  
A little  




Cows milk  
Egg  
Gluten (eg wheat, oats)  
Fruit   
Other (please describe)  
Breathing problems  
Vomit  
Diarrhea  
Stomach pain  
Rashes   
Irritability  
Other (please describe)  
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31c.Has your child been treated by a doctor for allergies to 
any of these foods? (PLEASE TICK ALL THAT APPLY)  
If you have ticked ‘other’, please describe the  







32. Does your child have brothers and sisters who have the same 









33. How many children under 16 live in your household?                          
                                                     (PLEASE FILL IN NUMBER) 
 
34. How many adults over 16 usually live in your household?  
                                                     (PLEASE FILL IN NUMBER) 
 
35. How many rooms are there in your house, not counting 
kitchens, bathrooms and toilets? (PLEASE FILL IN NUMBER) 
 
36. At what age did the child’s mother finish full-time education? 
(PLEASE FILL IN AGE) 
 
37. Which fuel is mainly used for cooking in your home? 
 
                                                                                  
Peanuts  
Cows milk  
Egg  
Gluten (eg wheat, oats)  
Fruit   
Other (please describe)  
Yes  
No  
If yes, how many? (please fill in number)  
Asthma or wheezing? (please fill in number)  
Hay fever? (please fill in number)  







Other fuel  
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38. How do you heat your home? (PLEASE 






39. Is there visible damp within the house?  
 
 
If there is visible damp, which rooms is it in? 
(PLEASE TICK ALL THAT APPLY) 
 
 







41. Is your child exposed to animals? 
(By exposed we mean do they come into close 
contact with any animals on a regular basis) 
 
If yes, which of the following animals? 
Electric central heating  
Gas central heating  
Central heating with other fuel, e.g. oil  
Heaters in rooms  





Child’s bedroom  
Other living areas  
Carpet  
Laminate  
Laminate with rug  




Follow up questionnaire                                                                                              SKI/Version 5.0/01Jul12 




(PLEASE TICK ALL THAT APPLY) 
If your child is exposed to other animals that are not on the list,  






42. Does the child’s mother smoke cigarettes?                                       
       
                           




43. Do any other household members smoke cigarettes?            
                  
 
If yes, how many per day (total cigarettes smoked by 
household members other than mother)?  
 
                                                                      
 
44. How would you best describe 
the location of your house? 
(PLEASE TICK THE ONE THAT 
BEST APPLIES) 
 
45. Did you have any problems understanding this questionnaire?                    
 
 


















1 to 10  
11 to 20  
More than 20  
Yes  
No  
1 to 10  
11 to 20  
More than 20  
In a street with very dense traffic (main road)  
In a street with moderate traffic (residential road)  
In a quiet street with little or no traffic  
Yes  
No  
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Thank you for completing the questionnaire. It will cost you nothing to return it if you use the pre-
paid envelope provided. 
 
For any queries please do not hesitate to contact us: 
Ms Liz Lance, Dr Kaninika Basu; Contact: 01273 696955, ext 2404, 2353 
Liz.Lance@bsuh.nhs.uk, k.basu@bsms.ac.uk 
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The Influence of genetic and environmental factors on childhood diseases 
 
Postal questionnaire to assess asthma/allergy: Year 2 
 
Thank you for agreeing to participate in our study. Please fill out this questionnaire with the 
information about the first 2 years of your child’s life and return it in the pre-paid envelope that has 
been supplied. 
 
How to complete the questionnaire: Please tick the appropriate box 
Example: Person completing questionnaire (tick box please): 
                                                  Mother    Father      Other 
 
 
Name of Child: …………………………………………  Bar Code Sticker 
 
 
Date of Birth: …………………………………………… 
 
 Person completing questionnaire (tick box please): 
                                                                    Mother    Father    Other  
 
 Date questionnaire completed:          day ____ month ______ year ________                           
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1. In the last year, has your child had an ITCHY skin condition - by itchy we mean 
scratching or rubbing the skin)?                   
                      
IF YOU HAVE ANSWERED ‘NO’ PLEASE SKIP TO QUESTION 2 
IF YOU HAVE ANSWERED ‘YES’ PLEASE ANSWER THE QUESTIONS IN THE SHADED BOX 
BELOW: 
1b. Was this ITCHY skin condition coming and going for at least six months?  
 




1d. How old was your child when this skin condition began?                          months old 
 
1e. Has this skin condition ever affected the skin creases in the past –  
by skin creases we mean fronts of elbows, behind the knees, front of  
ankles, around the neck or around the eyes?                 
 




3.   Between 12 and 24months, has your child suffered from any of the 
following skin complaints: (PLEASE TICK ALL THAT APPLY).       
 
 
4. Between 12 and 24months, has your child ever had wheezing or whistling in 
the chest? By “wheezing” we mean breathing that makes a high-pitched whistling or 













Facial spots  
Nappy rash  
Yes  
No  
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IF YOU HAVE ANSWERED ‘NO’ PLEASE SKIP TO QUESTION 12 
IF YOU HAVE ANSWERED ‘YES’ PLEASE ANSWER THE QUESTIONS IN THE SHADED BOX 
BELOW: 
 
 4a.  How old was your child when he/she first began to wheeze?  
             
5.  In the second year, has your child had wheezing or whistling in the chest 
during or soon after a cold or flu? 
                                                                                                         











 8. Which of these two descriptions fits best your child’s wheeze?   (TICK ONE ONLY) 
 
9. Between 12 and 24months, how often, on average, 







1 to 3  
4 to 12  
More than 12  
Yes, always  
Most of the time  
Occasionally  
No, never  
My child has only short attacks of wheeze, for example with colds. In between these attacks, 
he/she does not normally wheeze    
 
My child wheezes always or a lot of the time. With colds he/she has attacks with more severe 
wheeze   
 
never woken with wheezing    
less than one night per week    
one or more nights per week    
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10. Between 12 and 24months, did any of the following things cause wheezing in your child? 
                                                                      Feeding; playing; exercise?  









                                                         Contact with pets or other animals? 
 
 





11. Looking back between 12 and 24months, do you think that your child had 
asthma?                                                                                         
 
12. Does your child usually have a cough with colds?                                        
   
 




14. Do you think that your child coughs more than other children?        
 
 
15. Between 12 and 24months, has your child had a dry cough at night, apart from 






Don’t know  
Yes  
No  
Don’t know  
Yes  
No  
Don’t know  
Yes  
No  





Yes, always  
Yes, sometimes  
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16. Between 12 and 24months, did the following things cause coughing in your child? 
 
                                                              Feeding, playing or exercise?  
 
 
      laughing, crying or excitement?                                                                                                            
 
 
                                       
                                                      contact with pets or other animals? 
 
 




17. How often did your child see the GP for coughing or wheezing 
between 12 and 24months? 
 
 
             
18. Between 12 and 24months, has wheezing or asthma resulted in your child: 
 
                                                          being referred to a consultant in hospital  
                                       
                                                                                 being admitted to hospital         
                                                        
 
                                                   attending the casualty (A and E) department   
        
                                                  






Don’t know  
Yes  
No  
Don’t know  
Yes  
No  
Don’t know  
Yes  
No  
Don’t know  
Never  
Once  
2-3 times  
4-6 times  
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19. Did your child take any of the following drugs between 12 and 24months? 
                                 Salbutamol, Ventolin, Bricanyl or other blue inhaler     
 
 
                             





                                    Steroid tablets (prednisolone) for asthma attacks   
 
 
20. Between 12 and 24months, did your child suffer 





21. In the second year, how many times has your child 









23. Between 12 and 24months, has your child had a problem with sneezing,  
or a runny, or blocked nose when he/she did NOT have a cold or the flu?  
 
24. Between 12 and 24months, how much did this nose problem  




Don’t know  
Yes  
No  
Don’t know  
Yes  
No  
Don’t know  
Never  
Only with a cold  
Sometimes even without a cold  
Almost always  
Never  
1-3 times  
4-6 times  
7-10 times  
More than 10 times  
Less than 1 week  
1 to 2 weeks  
2 to 4 weeks  
More than 4 weeks  
Yes  
No  
Not at all  
A little  
A moderate amount  
A lot  
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25. Between 12 and 24months, has your child snored at night?                       
        
IF YOU HAVE ANSWERED ‘NO’ PLEASE SKIP TO QUESTION 26 
IF YOU HAVE ANSWERED ‘YES’ PLEASE ANSWER THE QUESTIONS IN THE SHADED BOX 
BELOW: 
 




25.b  Did the snoring disturb your child’s sleep? 
 
 
                         
 
 
26. Between 12 and 24months, has your child had any ear 
infections? 
 
27. Has your child ever suffered from any of the following conditions? 
                                                                                                                                                       
                                                                                  pneumonia?         
 
       
                                               
                                                        whooping cough?  
 
                                                                              
 




                                      
                                                                                       croup? 
    
Yes  
No  
Only with a cold  
Sometimes even without a cold  
Almost always  
Not at all  
A little  
A moderate amount  
A lot  
No, never  
Yes, once  
Yes, more than once  
No, never  
Yes, once  
Yes, more than once  
No, never  
Yes, once  
Yes, more than once  
No, never  
Yes, once  
Yes, more than once  
No, never  
Yes, once  
Yes, more than once  
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28. Does your child attend day care, childminder, nursery school or 
play school?  
 
29. Was your child breastfed?                       
                                                       
 
If yes, how long:             
                                                                                                              
 
 
30. Between 12 and 24 months, did your child posit or vomit?  
 
                                                                                               
 
 
31. Do you think your child has a reaction to any food items? 
 
 
IF YOU HAVE ANSWERED ‘NO’ PLEASE SKIP TO QUESTION 32 
IF YOU HAVE ANSWERED ‘YES’ PLEASE ANSWER THE QUESTIONS IN THE SHADED BOX BELOW: 
31a. Does your child have a reaction to any of these foods? 
(PLEASE TICK ALL THAT APPLY) 
 
If you have ticked ‘other’, please describe the  
type of food that causes the reaction:……….. 
…………………………………………………… 
 
31b. What type of reaction does the food cause? (PLEASE 
TICK ALL THAT APPLY)  
 
If you have ticked ‘other’, please describe the  








less than a month   
1-3 months   
4-6 months  
more than 6 months  
Not at all  
A little  




Cows milk  
Egg  
Gluten (eg wheat, oats)  
Fruit   
Other (please describe)  
Breathing problems  
Vomit  
Diarrhea  
Stomach pain  
Rashes   
Irritability  
Other (please describe)  
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31c.Has your child been treated by a doctor for allergies to 
any of these foods? (PLEASE TICK ALL THAT APPLY)  
If you have ticked ‘other’, please describe the  







32. Does your child have brothers and sisters who have the same 









33. How many children under 16 live in your household?                          
                                                     (PLEASE FILL IN NUMBER) 
 
34. How many adults over 16 usually live in your household?  
                                                     (PLEASE FILL IN NUMBER) 
 
35. How many rooms are there in your house, not counting 
kitchens, bathrooms and toilets? (PLEASE FILL IN NUMBER) 
 
36. At what age did the child’s mother finish full-time education? 
(PLEASE FILL IN AGE) 
 
37. Which fuel is mainly used for cooking in your home? 
 
                                                                                  
Peanuts  
Cows milk  
Egg  
Gluten (eg wheat, oats)  
Fruit   
Other (please describe)  
Yes  
No  
If yes, how many? (please fill in number)  
Asthma or wheezing? (please fill in number)  
Hay fever? (please fill in number)  







Other fuel  
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38. How do you heat your home? (PLEASE 






39. Is there visible damp within the house?  
 
 
If there is visible damp, which rooms is it in? 
(PLEASE TICK ALL THAT APPLY) 
 
 







41. Is your child exposed to animals? 
(By exposed we mean do they come into close 
contact with any animals on a regular basis) 
 
If yes, which of the following animals? 
Electric central heating  
Gas central heating  
Central heating with other fuel, e.g. oil  
Heaters in rooms  





Child’s bedroom  
Other living areas  
Carpet  
Laminate  
Laminate with rug  
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(PLEASE TICK ALL THAT APPLY) 
If your child is exposed to other animals that are not on the list,  






42. Does the child’s mother smoke cigarettes?                                       
       
                           




43. Do any other household members smoke cigarettes?            
                  
 
If yes, how many per day (total cigarettes smoked by 
household members other than mother)?  
 
                                                                      
 
44. How would you best describe 
the location of your house? 
(PLEASE TICK THE ONE THAT 
BEST APPLIES) 
 
45. Did you have any problems understanding this questionnaire?                    
 
 


















1 to 10  
11 to 20  
More than 20  
Yes  
No  
1 to 10  
11 to 20  
More than 20  
In a street with very dense traffic (main road)  
In a street with moderate traffic (residential road)  
In a quiet street with little or no traffic  
Yes  
No  
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Thank you for completing the questionnaire. It will cost you nothing to return it if you use the pre-
paid envelope provided. 
 
For any queries please do not hesitate to contact us: 
Ms Liz Lance, Dr Kaninika Basu; Contact: 01273 696955, ext 2404, 2353 
Liz.Lance@bsuh.nhs.uk, k.basu@bsms.ac.uk 
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Methods   28 
The GO-CHILD study is a longitudinal study of a birth-cohort of 2312 infants born to 29 
mothers recruited from antenatal clinics in 8 different National Health Service (NHS) trusts 30 
in England and Scotland, between March 2009 and July 2015. The quality control procedures 31 
followed 'Good Clinical Practice' guidelines1. The study is reported in accordance with the 32 
STROBE checklist. 2    The study was approved by the Tayside Committee on Medical 33 
Research and Ethics.  34 
 35 
At all the sites, an information leaflet about the study was given to all expecting mothers at 36 
their 12-week scan appointment and at any other antenatal visit from 12 weeks gestation 37 
onwards. Informed written consent was obtained prior to recruitment. The children were 38 
followed-up until the age of 2 years. All neonates born at term were eligible for inclusion in 39 
the study; and infants with any perinatal insult such as perinatal asphyxia, significant 40 
respiratory difficulty, or congenital anomalies were excluded.  41 
We estimated the required sample size based on the findings reported in a letter in Nature 42 
Genetics published a few years before we designed this study3. This study showed that a 43 
small sample size of the first publication and a large number of studies were independent 44 
predictors of discrepancies identified on subsequent meta-analyses of genetic association 45 
studies. The authors noted statistically significant discrepancies in 5 of 7 cases in which the 46 
first publications had a sample size of less than 150, compared with 3 of 29 when the sample 47 
size of the first study or studies was more than 150. We allowed for a relatively high level of 48 
attrition and aimed for an antenatal cohort size exceeding n=2000, aiming to achieve a 49 
sample size over 150 for all the analyses.  50 
 51 
 52 
Detailed study design is described in online figure 1. The antenatal questionnaire collected 53 
information on family history of atopic conditions, environmental exposure to the child and 54 
parental smoking. The children were followed up for symptoms related to atopy, at the ages 55 
of 6, 12 and 24 months by postal questionnaires. These questionnaires were used to collect 56 
comprehensive information on respiratory, nasal and dermatological outcomes, precipitating 57 
environmental factors such as exposure to smoking and animals, and the effects of these 58 
conditions in relation to daily activities. These questions related to dry skin, eczema, wheeze, 59 
upper respiratory conditions and food allergies, and how these symptoms affected the child's 60 
life, including any visits to primary or secondary care and the prescribing of medication. For 61 
simplicity and greater accuracy through recall, only yes/no responses for any of the three 62 
options (yes, no, don’t know) were used for analysis. The questionnaires were developed 63 
based on the Leicestershire questionnaire4 and were modified to make them relevant for 64 
younger children and also for the general population and not targeted towards children with 65 
asthma or wheeze.  66 
 67 
'Wheeze' was defined as 'breathing that makes a high-pitched whistling or squeaking sound 68 
from the chest, not the throat' and 'rhinitis' was defined as ' a problem with sneezing, or a 69 
runny, or blocked nose when he/she did NOT have a cold or the flu '. 'Dry and itchy skin' was 70 
the parental report of generally dry and itchy skin but not including affected skin creases, 71 
'respiratory impairment' was defined as any respiratory symptom affecting day-to-day life 72 
such as shortness of breath, disturbed sleep, dry nocturnal cough, and the nasal symptoms 73 
affecting day-to-day life comprised either or all of decreased daily activity due to rhinitis, 74 
snoring and sleep disturbance due to nasal symptoms. 75 
 76 
 Cord blood samples were collected at the time of delivery for genotyping. In absence of cord 77 
blood, a sample of saliva was collected in the postnatal period. Expecting mothers were 78 
invited through posters and leaflets to join the study at the time of their antenatal visits. Cord 79 
blood samples were collected at the time of delivery for genotyping. If this was unsuccessful, 80 
a sample of saliva (Oragene Neonatal Saliva Collection Kit, DNA Genotek, Ottawa, Canada 81 
K2G5W6) was collected in the postnatal period. The sample was collected by the researchers 82 
either at home or in the hospital, or posted to the researchers after collection at home by the 83 
family. The cord blood samples were stored at -80°C at the individual sites and later 84 
transported in batches to the Biomedical Research Institute, Dundee, for genotyping.  The 85 
saliva was obtained from the infant using the Oragene Neonatal saliva sample collection kit 86 
(DNA Genotek, 29 Camelot Drive, Ottawa, Ontario, Canada K2G5W6). The sample was 87 
collected by the researchers either at home or in the hospital, or by the mother at home and 88 
posted to the researchers.   All the genetic analyses are anonymised. 89 
 90 
Genotyping for FLG R501X and 2282del4 was performed as described in our earlier 91 
publication5. AA refers to the wild- type FLG genotype for R501X, 2282del4, S3247X and 92 
R2447X mutations, Aa refers to heterozygous genotype for either of R501X, 2282del4, 93 
S3247X and R2447X, and aa refers to homozygous genotype for either of R501X, 2282del4, 94 
S3247X or R2447X. The homozygous, heterozygous and compound heterozygous genotypes 95 
were considered together as Aa/aa. 96 
 97 
Data analyses were conducted using the IBM SPSS Statistics 146 software, Version 23 (IBM 98 
Corp., Armonk, and New York, USA), Stata version 15.1 (College Station, TX: StataCorp 99 
LLC) and Instat for Macintosh programmes. The chi-square test was used to compare the 100 
effects of the mutations on the atopic outcomes such as eczema, wheeze, rhinitis and dry or 101 
itchy skin. Significance was assessed at P <0.05. We have fitted log-binomial models to 102 
report relative risks and report estimates with 95% CIs; and we have additionally fitted log-103 
binomial models by generalised estimating equations with an unstructured correlation matrix 104 
(to account for the lack of independence between repeated measurements, accepting that 105 
there are insufficient repeated measurements to estimate an autoregressive correlation 106 
structure).  We report the results of the repeated measurements analysis in Table 5. 107 
We also performed binary logistic regression for the 4 atopic outcomes individually at each 108 
time point separately and subsequently log-binomial regressions for each outcome to obtain 109 
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Figure 1: Study design 
Time of contact                                                              Procedure 
 
12 weeks gestation to delivery                             Information leaflet 
                                                          
                                                                                       Recruitment 
 
 
                                                            
                                                  Essential                                         Additional 
                                     Antenatal questionnaire            Antenatal diet questionnaire  
                                                                                                                   
At delivery                    Collection of cord blood 
                                                       OR 
Any time                       Collection of saliva if cord blood  
                                        not obtained 
 
3 months of age                                                  3month dietary questionnaire  
                                                                                                                      
 
6months of age                                                               6month follow-up questionnaire  
                                                                                                                        
 
9 months of age                                                    9month dietary questionnaire   
                                                                                                                        
 
12 months of age 12 month follow-up questionnaire   
 
 
24 months of age 24 month follow-up questionnaire  
                                      Skin prick test   
 
Figure 2: Incidence (%) of  atopy-related clinical outcomes during the first 2 years of life in 
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Table1a. Characteristics of the GO-CHILD antenatal cohort (n=2312)   
FLG mutation  AA: 1263 (88%) 
Aa/aa: 168 (12%) 
Exposure to animals1  311 (13%) 
Exposure to smoke 92 (4%) 
Family history of asthma 1143 (49%) 
Family history of eczema 975 (42%) 
Family history of rhinitis 1134 (49%) 
Ethnicity (n=1489) Caucasian: 1387 (93%) 
(including mixed Caucasian 18) (1.2%) 
Asian: 26 (1.7%) 
Black: 16 (1.1%) 





Table 1b. Number (%) of parent reported skin, respiratory and nasal symptoms  
Clinical outcomes During first 6 
months 
(n=910*) 
During first year 
(n=1176*) 
During second year 
(n=962*) 
Eczema 257 (28%) 372 (32%) 311 (32%) 
Dry or itchy skin1 480 (53%) 559 (47%) 439 (46%) 
Wheeze 123 (13%) 268 (23%) 206 (21%) 
Respiratory impairment 2 96 (10%) 242 (21%) 188 (19%) 
Rhinitis3 236 (26%) 263 (22%) 195 (20%) 
Nasal symptoms affecting day-to-
day life4 
521 (57%) 545 (46%) 435 (45%) 
Parental report of asthma Not applicable 56 (5%) 62 (6%) 
 
*Number of returned questionnaires 
1Dry or itchy skin is parental report of generally dry or itchy skin but not including affected skin 
creases 
2Respiratory impairment is any respiratory symptom affecting day-to-day life such as shortness of 
breath, disturbed sleep, dry nocturnal cough   
3 A problem with sneezing, or a runny, or blocked nose when he/she did not have a cold or the flu 
4Nasal symptoms affecting day-to-day life is either or all of decreased daily activity due to rhinitis, 




Table 2. Associations between FLG genotype (co-dominant and mutant variants) and eczema, 



















† Adjusted odds ratio as log-binomial model non-convergent 
*Number of participants with FLG genotyping and returned questionnaires at 6 month time-point 
** Adjusted for exposure to day care and animals 
aa: Homozygous R501X or 2282del4 genotype or compound heterozygous genotype  
Aa: Heterozygous genotype for either R501X or 2282del4  
AA: Wild- type/ wild- type FLG   genotype for R501X and 2282del4 mutation 
 Filaggrin AA Aa/aa Total Adjusted Relative 
Risk** 
(95% CI) 




Yes 150 35 185 
Total 598 79 677 
Dry or 
itchy skin 
No 304 22 326 †2.71 
(1.61, 4.55) Yes 294 57 351 
Total 598 79 677 
Wheeze No 525 63 588 1.63  
(1.00, 2.65) Yes 73 16 89 
Total 598 79 677 
Rhinitis No 449 50 499 1.46 
(1.06, 2.01) Yes 149 29 178 




Table 3. Associations between FLG genotype (co-dominant and mutant variants) and eczema, 




















† Adjusted odds ratio as log-binomial model non-convergent 
*Number of participants with FLG genotyping and returned questionnaires at 12 month time-point 
** Adjusted for exposure to day care and animals 
aa: Homozygous R501X or 2282del4 genotype or compound heterozygous genotype  
Aa: Heterozygous genotype for either R501X or 2282del4  
AA: Wild- type/ wild- type FLG   genotype for R501X and 2282del4 mutation 
 Filaggrin AA Aa/aa Total Adjusted relative 
risk** 
(95% CI) 
Eczema No 507 46 553 1.80   
(1.39,   2.32) 
 
Yes 207 49 256 
Total 714 95 809 
Dry or 
itchy skin 
No 399 30 429 †2.28    
(1.32, 3.92) Yes 315 65 380 
Total 714 95 809 
Wheeze No 552 66 618 1.45  
(0.98, 2.13) Yes 162 29 191 
Total 714 95 809 
Rhinitis No 560 70 630 1.48  
(0.99, 2.22) Yes 154 25 179 
Total 714 95 809 
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Table 4.  Associations between FLG genotype (co-dominant and mutant variants) and eczema, 




















† Adjusted odds ratio as log-binomial model non-convergent 
*Number of participants with FLG genotyping and returned questionnaires at 24 month time-point 
** Adjusted for exposure to day care and animals 
aa: Homozygous R501X or 2282del4 genotype or compound heterozygous genotype  
Aa: Heterozygous genotype for either R501X or 2282del4  
AA: Wild- type/ wild- type FLG   genotype for R501X and 2282del4 mutation 
 Filaggrin AA Aa/aa Total Adjusted relative 
risk** 
(95% CI) 
Eczema No 409 46 455 1.40   
(1.00, 1.97) 
Yes 171 38 209 
Total 580 84 664 
Dry or 
itchy skin 
No 332 32 364 †1.83 
(1.02, 3.28) Yes 248 52 300 
Total 580 84 664 
Wheeze No 460 66 526 0.84  
(0.47, 1.51) Yes 120 18 138 
Total 580 84 664 
Rhinitis No 468 60 528 1.38    
(0.84, 2.25) Yes 112 24 136 




Table 5.  Associations between FLG genotype (co-dominant and mutant variants) and eczema, 




Eczema 1.70 (1.38, 2.11) 
Dry or itchy skin 
(n=559) 
†2.02 (1.25, 3.26) 
Wheeze 1.29 (0.92, 1.81) 
Rhinitis 1.42 (1.11, 1.83) 
 
† Adjusted odds ratio as log-binomial model non-convergent 
** adjusted for exposure to day care and animals 
aa: Homozygous R501X or 2282del4 genotype or compound heterozygous genotype  
Aa: Heterozygous genotype for either R501X or 2282del4  
AA: Wild- type/ wild- type FLG   genotype for R501X and 2282del4 mutation 
 
 
